Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 24Breast Neoplasms 11Prostatic Neoplasms 10Colorectal Neoplasms 10Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Advanced Cancer 4Uterine Cervical Neoplasms 3Rectal Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Sarcoma 2Peritoneal Neoplasms 2Pain 2Neoplasm Metastasis 2Mouth Neoplasms 2Melanoma 2Low Anterior Resection Syndrome 2Hematopoietic and Lymphoid System Neoplasm 2Fatigue 2Endometrial Neoplasms 2Depression 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2

Interventions

Carboplatin 41Paclitaxel 40pembrolizumab 38Cyclophosphamide 23Gemcitabine 22130-nm albumin-bound paclitaxel 21Doxorubicin 18Cisplatin 18Albumin-Bound Paclitaxel 18atezolizumab 16Taxes 15Capecitabine 13veliparib 10Nivolumab 9Docetaxel 9Bevacizumab 9olaparib 8liposomal doxorubicin 7Everolimus 7spartalizumab 6durvalumab 6Epirubicin 6trametinib 5pegfilgrastim 5eribulin 5Irinotecan 5Filgrastim 5iniparib 4binimetinib 4apatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Triple Negative Breast Neoplasms × Interviews as Topic × Clear all
NCT05071677 2023-08-09

Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer

M.D. Anderson Cancer Center

Completed
30 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡